A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis

Journal of Immunology

Volumn 186, Issue 8, 2011, Pages 4994-5003

  Bethunaickan, Ramalingam ^a   Berthier, Celine C ^b   Ramanujam, Meera ^a   Sahu, Ranjit ^a   Zhang, Weijia ^c   Sun, Yezou ^c   Bottinger, Erwin P ^c   Ivashkiv, Lionel ^d   Kretzler, Matthias ^b   Davidson, Anne ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; CYCLOPHOSPHAMIDE; MATRIX METALLOPROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CELL COUNT; CELL SURFACE; CELL VACUOLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLOMERULOPATHY; HYBRID CELL; INFLAMMATION; INFLAMMATORY CELL; KIDNEY; KIDNEY CELL; LUPUS ERYTHEMATOSUS NEPHRITIS; MACROPHAGE; MONONUCLEAR PHAGOCYTE; MOUSE; NEPHRITIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEINURIA; REMISSION; TISSUE REPAIR; TURNOVER TIME; UPREGULATION;

ANIMALS; ANTIGENS, DIFFERENTIATION; BLOTTING, WESTERN; CYCLOPHOSPHAMIDE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; KIDNEY; LEUKOCYTES, MONONUCLEAR; LUPUS NEPHRITIS; MACROPHAGES; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED NZB; MICE, INBRED STRAINS; MICROSCOPY, ELECTRON, SCANNING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHAGOCYTES; REMISSION INDUCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 79955018853     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003010     Document Type: Article

References (57)

1. Hill, G. S., M. Delahousse, D. Nochy, P. Rémy, F. Mignon, J. P. Méry, and J. Bariéty. 2001. Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages. Kidney Int. 59:304-316. (Pubitemid 32063019)
2. Sean Eardley, K., and P. Cockwell. 2005. Macrophages and progressive tubulointerstitial disease. Kidney Int. 68:437-455. (Pubitemid 43323099)
3. Knight, S. F., J. E. Quigley, J. Yuan, S. S. Roy, A. Elmarakby, and J. D. Imig. 2008. Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet. Hypertension 51:352-359. (Pubitemid 351159950)
4. Bergtold, A., A. Gavhane, V. D'Agati, M. Madaio, and R. Clynes. 2006. FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis. J. Immunol. 177:7287-7295. (Pubitemid 44715098)
5. Mosser, D. M. 2003. The many faces of macrophage activation. J. Leukoc. Biol. 73:209-212. (Pubitemid 36158295)
6. Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25:677-686. (Pubitemid 39457982)
7. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:958-969.
8. Hume, D. A. 2008. Differentiation and heterogeneity in the mononuclear phagocyte system. Mucosal Immunol. 1:432-441.
9. Gordon, S., and F. O. Martinez. 2010. Alternative activation of macrophages: mechanism and functions. Immunity 32:593-604.
10. Martinez, F. O., A. Sica, A. Mantovani, and M. Locati. 2008. Macrophage activation and polarization. Front. Biosci. 13:453-461. (Pubitemid 351599757)
11. Wang, L., R. A. Gordon, L. Huynh, X. Su, K. H. Park Min, J. Han, J. S. Arthur, G. D. Kalliolias, and L. B. Ivashkiv. 2010. Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins. Immunity 32:518-530.
12. Krüger, T., D. Benke, F. Eitner, A. Lang, M. Wirtz, E. E. Hamilton-Williams, D. Engel, B. Giese, G. Müller-Newen, J. Floege, and C. Kurts. 2004. Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J. Am. Soc. Nephrol. 15:613-621. (Pubitemid 38294791)
13. Soos, T. J., T. N. Sims, L. Barisoni, K. Lin, D. R. Littman, M. L. Dustin, and P. J. Nelson. 2006. CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int. 70:591-596. (Pubitemid 44141588)
14. Segerer, S., F. Heller, M. T. Lindenmeyer, H. Schmid, C. D. Cohen, D. Draganovici, J. Mandelbaum, P. J. Nelson, H. J. Gröne, E. F. Gröne, et al. 2008. Compartment specific expression of dendritic cell markers in human glomerulonephritis. Kidney Int. 74:37-46. (Pubitemid 351841902)
15. Ferenbach, D., and J. Hughes. 2008. Macrophages and dendritic cells: what is the difference? Kidney Int. 74:5-7. (Pubitemid 351841897)
16. Geissmann, F., C. Auffray, R. Palframan, C. Wirrig, A. Ciocca, L. Campisi, E. Narni-Mancinelli, and G. Lauvau. 2008. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol. Cell Biol. 86:398-408. (Pubitemid 351948210)
17. Li, L., L. Huang, S. S. Sung, A. L. Vergis, D. L. Rosin, C. E. Rose, Jr., P. I. Lobo, and M. D. Okusa. 2008. The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int. 74:1526-1537.
18. Kurts, C. 2006. Dendritic cells: not just another cell type in the kidney, but a complex immune sentinel network. Kidney Int. 70:412-414. (Pubitemid 44141566)
19. Schiffer, L., J. Sinha, X. Wang, W. Huang, G. von Gersdorff, M. Schiffer, M. P. Madaio, and A. Davidson. 2003. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J. Immunol. 171:489-497. (Pubitemid 36745324)
20. Schiffer, L., R. Bethunaickan, M. Ramanujam, W. Huang, M. Schiffer, H. Tao, M. P. Madaio, E. P. Bottinger, and A. Davidson. 2008. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J. Immunol. 180:1938-1947.
21. Xie, C., R. Sharma, H. Wang, X. J. Zhou, and C. Mohan. 2004. Strain distribution pattern of susceptibility to immune-mediated nephritis. J. Immunol. 172:5047-5055. (Pubitemid 38456432)
22. Ramanujam, M., X. Wang, W. Huang, Z. Liu, L. Schiffer, H. Tao, D. Frank, J. Rice, B. Diamond, K. O. Yu, et al. 2006. Similarities and differences between selective and nonselective BAFF blockade in murine SLE. J. Clin. Invest. 116:724-734. (Pubitemid 43326881)
23. Nahrendorf, M., F. K. Swirski, E. Aikawa, L. Stangenberg, T. Wurdinger, J. L. Figueiredo, P. Libby, R. Weissleder, and M. J. Pittet. 2007. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204:3037-3047. (Pubitemid 350179569)
24. Tusher, V. G., R. Tibshirani, and G. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98:5116-5121. (Pubitemid 32397092)
25. Ginhoux, F., K. Liu, J. Helft, M. Bogunovic, M. Greter, D. Hashimoto, J. Price, N. Yin, J. Bromberg, S. A. Lira, et al. 2009. The origin and development of nonlymphoid tissue CD103+ DCs. J. Exp. Med. 206:3115-3130.
26. Wiggins, J. E., S. R. Patel, K. A. Shedden, M. Goyal, B. L. Wharram, S. Martini, M. Kretzler, and R. C. Wiggins. 2010. NFkappaB promotes inflammation, coagulation, and fibrosis in the aging glomerulus. J. Am. Soc. Nephrol. 21:587-597.
27. Schmid, H., A. Boucherot, Y. Yasuda, A. Henger, B. Brunner, F. Eichinger, A. Nitsche, E. Kiss, M. Bleich, H. J. Gröne, et al; European Renal cDNA Bank (ERCB) Consortium. 2006. Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 55:2993-3003. (Pubitemid 44923635)
28. Frisch, M., B. Klocke, M. Haltmeier, and K. Frech. 2009. LitInspector: literature and signal transduction pathway mining in PubMed abstracts. Nucleic Acids Res. 37 (Web Server issue): W135-W140.
29. Triantafyllopoulou, A., C. W. Franzke, S. V. Seshan, G. Perino, G. D. Kalliolias, M. Ramanujam, N. van Rooijen, A. Davidson, and L. B. Ivashkiv. 2010. Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proc. Natl. Acad. Sci. USA 107:3012-3017.
30. Ramanujam, M., P. Kahn, W. Huang, H. Tao, M. P. Madaio, S. M. Factor, and A. Davidson. 2009. Interferon-alpha treatment of female (NZW x BXSB) F (1) mice mimics some but not all features associated with the Yaa mutation. Arthritis Rheum. 60:1096-1101.
31. Ramanujam, M., R. Bethunaickan, W. Huang, H. Tao, M. P. Madaio, and A. Davidson. 2010. Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis in NZM2410 mice. Arthritis Rheum. 62:1457-1468.
32. Orvedahl, A., and B. Levine. 2009. Autophagy in Mammalian antiviral immunity. Curr. Top. Microbiol. Immunol. 335:267-285.
33. Santiago-Schwarz, F., A. Valentino, C. Martin, and C. DiMaio. 2010. IL-10 interruption of dendritic cell (DC) differentiation during the monocyte-to-DC transition is associated with increased levels of LC3, mature autophagosome formation, and survival of monocyte-macrophage-like cells. J. Immunol. 184:134.121.
34. Qu, X., Z. Zou, Q. Sun, K. Luby-Phelps, P. Cheng, R. N. Hogan, C. Gilpin, and B. Levine. 2007. Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 128:931-946. (Pubitemid 46341412)
35. Crotzer, V. L., and J. S. Blum. 2009. Autophagy and its role in MHC-mediated antigen presentation. J. Immunol. 182:3335-3341.
36. Münz, C. 2010. Selective macroautophagy for immunity. Immunity 32:298-299.
37. Chang, Y. P., C. C. Tsai, W. C. Huang, C. Y. Wang, C. L. Chen, Y. S. Lin, J. I. Kai, C. Y. Hsieh, Y. L. Cheng, P. C. Choi, et al. 2010. Autophagy facilitates IFN-gamma-induced Jak2-STAT1 activation and cellular inflammation. J. Biol. Chem. 285:28715-28722.
38. Mancino, A., T. Schioppa, P. Larghi, F. Pasqualini, M. Nebuloni, I. H. Chen, S. Sozzani, J. M. Austyn, A. Mantovani, and A. Sica. 2008. Divergent effects of hypoxia on dendritic cell functions. Blood 112:3723-3734.
39. Choi, Y. E., H. N. Yu, C. H. Yoon, and Y. S. Bae. 2009. Tumor-mediated downregulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter. Eur. J. Immunol. 39:858-868.
40. Tabas, I. 2010. Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 10:36-46.
41. Han, C., J. Jin, S. Xu, H. Liu, N. Li, and X. Cao. 2010. Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat. Immunol. 11:734-742.
42. Bouchon, A., F. Facchetti, M. A. Weigand, and M. Colonna. 2001. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410:1103-1107. (Pubitemid 32391042)
43. Yamasaki, S., E. Ishikawa, M. Sakuma, H. Hara, K. Ogata, and T. Saito. 2008. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat. Immunol. 9:1179-1188.
44. Pyz, E., A. S. Marshall, S. Gordon, and G. D. Brown. 2006. C-type lectin-like receptors on myeloid cells. Ann. Med. 38:242-251. (Pubitemid 43862326)
45. Hu, C., B. Y. Kang, J. Megyesi, G. P. Kaushal, R. L. Safirstein, and J. L. Mehta. 2009. Deletion of LOX-1 attenuates renal injury following angiotensin II infusion. Kidney Int. 76:521-527.
46. Holers, V. M. 2008. The spectrum of complement alternative pathway-mediated diseases. Immunol. Rev. 223:300-316. (Pubitemid 351986186)
47. Ishikawa, S., S. Nagai, T. Sato, K. Akadegawa, H. Yoneyama, Y. Y. Zhang, N. Onai, and K. Matsushima. 2002. Increased circulating CD11b+CD11c+ dendritic cells (DC) in aged BWF1 mice which can be matured by TNF-alpha into BLC/CXCL13-producing DC. Eur. J. Immunol. 32:1881-1887. (Pubitemid 34814543)
48. Perrier, P., F. O. Martinez, M. Locati, G. Bianchi, M. Nebuloni, G. Vago, F. Bazzoni, S. Sozzani, P. Allavena, and A. Mantovani. 2004. Distinct transcriptional programs activated by interleukin-10 with or without lipopolysaccharide in dendritic cells: induction of the B cell-activating chemokine, CXC chemokine ligand 13. J. Immunol. 172:7031-7042. (Pubitemid 38669145)
49. Aringer, M., G. Steiner, W. B. Graninger, E. Höfler, C. W. Steiner, and J. S. Smolen. 2007. Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus. Arthritis Rheum. 56:274-279. (Pubitemid 46106201)
50. Tenoever, B. R., S. L. Ng, M. A. Chua, S. M. McWhirter, A. García-Sastre, and T. Maniatis. 2007. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 315:1274-1278. (Pubitemid 46364264)
51. Laver, T., S. E. Nozell, and E. N. Benveniste. 2008. IFN-beta-mediated inhibition of IL-8 expression requires the ISGF3 components Stat1, Stat2, and IRF-9. J. Interferon Cytokine Res. 28:13-23. (Pubitemid 351171384)
52. Tsuno, T., J. Mejido, T. Zhao, H. Schmeisser, A. Morrow, and K. C. Zoon. 2009. IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha. J. Immunother. 32:803-816.
53. Chiang, S. H., M. Bazuine, C. N. Lumeng, L. M. Geletka, J. Mowers, N. M. White, J. T. Ma, J. Zhou, N. Qi, D. Westcott, et al. 2009. The protein kinase IKKepsilon regulates energy balance in obese mice. Cell 138:961-975.
54. Corr, M., D. L. Boyle, L. Ronacher, N. Flores, and G. S. Firestein. 2009. Synergistic benefit in inflammatory arthritis by targeting I kappaB kinase epsilon and interferon beta. Ann. Rheum. Dis. 68:257-263.
55. Kalechman, Y., U. Gafter, T. Weinstein, A. Chagnac, I. Freidkin, A. Tobar, M. Albeck, and B. Sredni. 2004. Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3. J. Biol. Chem. 279:24724-24732. (Pubitemid 38725340)
56. Ishida, H., T. Muchamuel, S. Sakaguchi, S. Andrade, S. Menon, and M. Howard. 1994. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179:305-310. (Pubitemid 24012996)
57. Lauwerys, B. R., N. Garot, J. C. Renauld, and F. A. Houssiau. 2000. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients. Arthritis Rheum. 43:1976-1981.